Cite

HARVARD Citation

    Uenaka, T. et al. (n.d.). In silico drug screening by using genome-wide association study data repurposed dabrafenib, an anti-melanoma drug, for Parkinson's disease. Human molecular genetics. pp. 3974-3985. [Online]. 
  
Back to record